According to this new data, patients on Afinitor tablets showed a significant reduction in tumour size and the absence of tumour progression. Approximately 42% of TSC patients on Afinitor had ...

for Everolimus tablets for oral suspension (TFOS) of strengths 2mg, 3mg and 5mg, Natco Pharma said in a regulatory filing. The drug is a generic version of AFINITOR DISPERZ by Novartis ...